Discovering interactions among BRCA1 and other candidate genes associated with sporadic breast cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 34, 2008, Pages 12387-12392

  Lo, Shaw Hwa ^a   Chernoff, Herman ^b   Cong, Lei ^a   Ding, Yuejing ^a   Zheng, Tian ^a  

^a Howard Hughes Medical Institute   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; FEMALE; GENE INTERACTION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BRCA1 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE REGULATORY NETWORKS; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 50449094836     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0805242105     Document Type: Article

References (35)

1. Meza JE, Brzovic PS, King MC, Klevit RE (1999) Mapping the functional domains of BRCA1 interaction of the ring finger domains of BRCA1 and BARD1. J Biol Chem 274:5659-5665.
2. Xia Y, Pao GM, Chen HW, Verma IM, Hunter T (2003) Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J Biol Chem 278:5255-5263.
3. Morris JR, Keep NH, Solomon E (2002) Identification of residues required for the interaction of BARD1 with BRCA1. J Biol Chem 277:9382-9386.
4. Scully R, et al. (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265-275.
5. Levy-Lahad E, et al. (2001) A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 98:3232-3236.
6. Vahteristo P, et al. (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432-438.
7. Osorio A, et al. (2004) The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer 108:54-56.
8. N. Johnson N, et al. (2005) Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. Lancet 366:1554-1557.
9. Meijers-Heijboer H, et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55-59.
10. CHEK2 Breast Cancer Consortium. (2004) CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74:1175-1182.
11. Hosey AM, et al. (2007) Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. J Natl Cancer Inst 99:1683-1694.
12. Fan S, et al. (1999) BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284:1354-1356.
13. Chatterjee N, Kalaylioglu Z, Moslehi R, Peters U, Wacholder S (2006) Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions. Am J Hum Genet 79:1002-1016.
14. Chapman J, Clayton D (2007) Detecting association using epistatic information. Genet Epidemiol 31:894-909.
15. Hunter DJ, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39:870.
16. Cox A, et al. (2007) A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39:352-358.
17. Karppinen SM, Heikkinen K, Rapakko K, Winqvist R (2004) Mutation screening of the BARD1 gene: Evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer. J Med Genet 41:e114.
18. Campbell IG, et al. (2004) Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64:7678-7681.
19. Holst F, et al. (2007) Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 39:655-660.
20. Chano T, Kontani K, Teramoto K, Okabe H, Ikegawa S (2002) Truncating mutations of RB1CC1 in human breast cancer. Nat Genet 31:285-288.
21. Wooster R, et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.
22. Borresen-Dale AL (2003) TP53 and breast cancer. Hum Mutat 21:292-300.
23. Cantor SB, et al. (2001) BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105:149-160.
24. Li L, Li X, Francke U, Cohen SN (1997) The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88:143-154.
25. Gallagher E, et al. (2006) Gain of imprinting of SLC22A18 sense and antisense transcripts in human breast cancer. Genomics 88:12-17.
26. Stredrick DL, et al. (2006) The ATM missense mutation p.Ser49Cys (c. 146C>G) and the risk of breast cancer. Hum Mutat 27:538-544.
27. Kranenburg O (2005) The KRAS oncogene: Past, present, and future. Biochim Biophys Acta 1756:81-82.
28. Xia B, et al. (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell, 22:719-729.
29. Xia B, et al. (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39:159-161.
30. Sato T, et al. (1992) The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res 52:1643-1646.
31. Bulavin DV, et al. (2002) Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet 31:210-215.
32. Lo SH, Zheng T (2002) Backward haplotype transmission association (BHTA) algorithm - A fast multiple-marker screening method. Hum Hered 53:197-215.
33. Lo SH, Zheng T (2004) A demonstration and findings of a statistical approach through reanalysis of inflammatory bowel disease data. Proc Natl Acad Sci USA 101:10386-10391.
34. Zheng T, Wang H, Lo SH (2006) Backward genotype-trait association (BGTA)-based dissection of complex traits in case-control designs. Hum Hered 62:196-212.
35. Ding Y, Cong L, Ionita-Laza I, Lo SH, Zheng T (2007) Constructing gene association networks for rheumatoid arthritis using the backward genotype-trait association (BGTA) algorithm. BMC Proc 1(Suppl 1):S13.